- Home
- BDL vs NTRB Comparison
BDL vs NTRB Comparison
Compare BDL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- NTRB
- Stock Information
- Founded
- BDL 1959
- NTRB 2016
- Country
- BDL United States
- NTRB United States
- Employees
- BDL N/A
- NTRB N/A
- Industry
- BDL Restaurants
- NTRB Industrial Specialties
- Sector
- BDL Consumer Discretionary
- NTRB Health Care
- Exchange
- BDL Nasdaq
- NTRB Nasdaq
- Market Cap
- BDL 60.8M
- NTRB 59.1M
- IPO Year
- BDL N/A
- NTRB N/A
- Fundamental
- Price
- BDL $29.05
- NTRB $9.99
- Analyst Decision
- BDL
- NTRB Buy
- Analyst Count
- BDL 0
- NTRB 1
- Target Price
- BDL N/A
- NTRB $13.00
- AVG Volume (30 Days)
- BDL 3.1K
- NTRB 128.8K
- Earning Date
- BDL 08-12-2025
- NTRB 09-02-2025
- Dividend Yield
- BDL 1.72%
- NTRB N/A
- EPS Growth
- BDL 14.76
- NTRB N/A
- EPS
- BDL 2.18
- NTRB N/A
- Revenue
- BDL $198,785,000.00
- NTRB $2,398,437.00
- Revenue This Year
- BDL N/A
- NTRB $560.75
- Revenue Next Year
- BDL N/A
- NTRB $588.39
- P/E Ratio
- BDL $13.31
- NTRB N/A
- Revenue Growth
- BDL 9.31
- NTRB 18.92
- 52 Week Low
- BDL $22.61
- NTRB $3.72
- 52 Week High
- BDL $35.98
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- BDL 45.79
- NTRB 69.95
- Support Level
- BDL $30.11
- NTRB $7.52
- Resistance Level
- BDL $35.18
- NTRB $11.68
- Average True Range (ATR)
- BDL 0.99
- NTRB 0.67
- MACD
- BDL -0.47
- NTRB 0.19
- Stochastic Oscillator
- BDL 0.00
- NTRB 62.19
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.